MarketingMedicalPolicy,Access,Value, andEvidenceConsultingData,Technology,and MediaMarketingMedicalPolicy,Access,Value, andEvidenceConsultingData,Technology,and MediaIntroducing
murmuration of birds
Previous
Next

thought leadership

From Part D Redesign to MFPs: Developments and Future Strategies

October 14, 2025

With the recent implementation of the Inflation Reduction Act’s (IRA) Part D redesign changes and new Maximum Fair Price (MFP) dynamics beginning in 2026, the Medicare Advantage (MA) and Part D landscape for contracting and formulary management is rapidly evolving. The effects of 2025 Part D changes on beneficiary utilization, plan spending, and manufacturer liability are still emerging, while early insights into the 2026 plan landscape are revealing how Part D plans and manufacturers are navigating these shifts across different plan types, beneficiary populations, and therapeutic areas. 

In this webinar, Avalere Health Advisory experts will explore emerging trends and implications for contracting, formulary strategies, and beneficiary access, including: 

  • Observed impacts of Part D redesign on stakeholders in 2025, including differences for standalone Prescription Drug Plans (PDPs) vs. Medicare Advantage Prescription Drug Plans (MA-PDs), interactions with risk adjustment changes, and effects on beneficiary utilization 
  • Early insights into 2026 plan offerings and formulary management changes 
  • How MFP implementation is influencing plan formulary strategies for 2026 IPAY drugs and their competitors 
  • Strategic considerations for CY 2027/2028 contracting, formulary positioning, and access approaches, as stakeholders incorporate lessons from Part D redesign and prepare for expanded MFP implementation within an evolving Part D environment 

 

Tune in to the webinar

Join us for a live discussion and Q&A on emerging trends and implications for contracting, formulary strategies, and beneficiary access.

Register today

 

Moderator:

  • Kylie Stengel, Principal, Policy

Panelists:

  • Mina Allo, Managing Director, Market Access
  • Neil Lund, Senior Advisor, Policy
  • Mark Newsom, Managing Director, Policy

We care about your privacy

By clicking "Accept all cookies", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

Manage my preferences

How we use cookies

Cookies are files saved on your phone, tablet or computer when you visit a website.

We use cookies to store information about how you use the Avalere Health website, such as the pages you visit.

For more information, check the cookie statement

32E8261E-A569-4B66-ACC6-3CB772DDEDEE

Cookie settings

We use 4 types of cookies. You can choose which cookies you're happy for us to use.

Cookies that measure website use.

We use Google Analytics to measure how you use the website so we can improve it based on user needs. We do not allow Google to use or share the data about how you use this site.

  • how you got to the site
  • the pages you visit on avalerehealth.com, and how long you spend on each page
  • what you click on while you're visiting the site

Cookies that help with our communications and marketing

These cookies may be set by third party websites and do things like measure how you view Vimeo videos that are on avalerehealth.com.

Cookies that remember your settings

These cookies do things like remember your preferences and the choices you make, to personalize your experience of using the site.

Strictly necessary cookies

These essential cookies do things like remember your progress through a form (eg. Registering for new content alerts).

These cookies always need to be on.